drugset / Trial / NCT00979615
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to examine safety and efficacy of Patanase and Astelin in treating the symptoms of non-allergic vasomotor rhinitis (VMR).
Timeline
- Start
- 2009-09
- Primary completion
- 2009-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azelastine | Small molecule | 137 ug | Intranasal |
| Subject | Olopatadine | Other / unclassified | 0.6 % | Intranasal |